NCT02776956View on ClinicalTrials.gov

Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Atrial Fibrillation
Interventions
DRUG

atorvastatin group

Patients in atorvastatin group will orally receive 20 mg of atorvastatin per night (Pfizer) for three days before the operation and three months after the operation

DRUG

non-atorvastatin group

Patients in non-atorvastatin group will not receive atorvastatin before the operation and after the operation.

Trial Locations (1)

050000

The Second Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

xieruiqin

OTHER

NCT02776956 - Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy | Biotech Hunter | Biotech Hunter